S121: REDUCED RATE OF VASO-OCCLUSIVE CRISES (VOCS) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) TREATED WITH CRIZANLIZUMAB FOR 12 MONTHS: RESULTS FROM A REAL-WORLD, MANAGED ACC...

por Silva-Pinto, A, Colombatti, R, Pasanisi, A, Arcioni, F, DeBonnett, L, Soliman, W, Sarkar, R, Cançado, R
Publicado 2022

P1491: REAL-WORLD INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB: RESULTS FROM A MANAGE...

por Silva-Pinto, A. C., Colombatti, R., Pasanisi, A., Arcioni, F., DeBonnett, L., Soliman, W., Sarkar, R., Cançado, R. D.
Publicado 2022

PB2224: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS)

por Ezzat, H., Al Zayed, A., Al Saeed, H., AlDarwish, M., Albagshi, M., Malhan, H., Tarawa, A., AlManea, A., AlHazmi, I., Qari, M., Al Jefr, A., Alzahrani, A., Alzahran, M., Soliman, W., Arsalan, M., Jastaniah, W.
Publicado 2022

P1497: BURDEN OF SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS)

por Jastaniah, W., Al Zayed, A., Al Saeed, H., AlDarwish, M., Albagshi, M., Malhan, H., Tarawa, A., AlManea, A., AlHazmi, I., Qari, M., Al Jefr, A., Alzahrani, A., Alzahran, M., Soliman, W., Askar, F., Ezzat, H.
Publicado 2022